You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 12, December 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dentistry/ Oral Medicine
 •Hypersensitivity
 •Immunotherapy
 •Alert me on articles by topic

Response of Oral Lichen Planus to Topical Tacrolimus in 37 Patients

Julie A. Byrd, MD; Mark D. P. Davis, MD; Alison J. Bruce, MD; Lisa A. Drage, MD; Roy S. Rogers III, MD

Arch Dermatol. 2004;140:1508-1512.

Background  Topical tacrolimus has been reported to be effective for the treatment of oral lichen planus. This article describes our experience with topical tacrolimus in patients treated for symptomatic oral lichen planus.

Observations  A survey was mailed to 40 patients with symptomatic oral lichen planus treated with topical tacrolimus. Surveys were completed by 37 patients (93%) a mean of 1.3 years after initiation of treatment. Thirty-three (89%) of the 37 patients reported symptomatic improvement, and 31 (84%) reported partial to complete lesion clearance while using topical tacrolimus. On average, patients noted improvement in 1 month. Twelve patients (32%) reported adverse effects consistent with those reported previously (ie, burning, irritation, and tingling). Among the 28 patients still using the medication, 15 patients (54%) apply it at least once daily. Of the 9 patients who discontinued using the medication, 5 experienced recurrence.

Conclusions  Topical tacrolimus is effective for the treatment of oral lichen planus. Most patients experienced symptomatic improvement in less than 1 month. However, the effect is temporary; when topical tacrolimus is discontinued, oral lichen planus may flare again.


Author Affiliations: Department of Dermatology, Mayo Clinic, Rochester, Minn.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Oral Erosive Lichen Planus With 1% Pimecrolimus Cream: A Double-blind, Randomized, Prospective Trial With Measurement of Pimecrolimus Levels in the Blood
Passeron et al.
Arch Dermatol 2007;143:472-476.
ABSTRACT | FULL TEXT  

New and Old Therapeutics for Oral Ulcerations
Bruce and Rogers
Arch Dermatol 2007;143:519-523.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.